Company news
Sinovac Biotech, Ltd. news in 2020
Sinovac Biotech, Ltd.'s news releases, calls and decks from 2020, newest first.
Sinovac Announces Product License for 23-Valent Pneumococcal Polysaccharide Vaccine
December 8, 2020
Sinovac Reports Unaudited Third Quarter 2020 Financial Results
December 6, 2020
Sinovac Secures Approximately $500 Million in Funding for COVID-19 Vaccine Development
December 5, 2020
Beijing Fourth Intermediate People’s Court Issues Judgement Against Sinobioway Medicine and Mr. Aihua Pan
September 27, 2020
Sinovac’s Coronavac™, SARS-CoV-2 Vaccine (Vero Cell), Inactivated, Announces Approval for Phase I/II Clinical Trial in Adolescents and Children
September 22, 2020
Sinovac Commences Phase III Clinical Trials for COVID-19 Vaccine Candidate in Turkey
September 21, 2020
Sinovac Reports Preliminary Phase I/II Results of COVID-19 Vaccine in Elderly Volunteers
September 8, 2020
Sinovac Reports Unaudited Second Quarter 2020 Financial Results
August 27, 2020
Sinovac Signs Agreement with Bio Farma Indonesia for COVID-19 Vaccine Cooperation
August 24, 2020
Sinovac COVID-19 Vaccine Collaboration with Butantan Receives Approval from Brazilian Regulator for Phase III Trial
July 5, 2020
Sinovac Reports Unaudited First Quarter 2020 Financial Results
June 29, 2020
Sinovac Receives Approval from China for its Quadrivalent Influenza Vaccine
June 23, 2020
Sinovac Announces Positive Preliminary Results of Phase I/II Clinical Trials for Inactivated Vaccine Candidate Against COVID-19
June 12, 2020
Sinovac and Butantan Join Efforts to Advance the Clinical Development of An Inactivated Vaccine for COVID-19 to Phase III
June 10, 2020
Sinovac Secures $15 Million in Funding to Accelerate COVID-19 Vaccine Development
May 21, 2020
Sinovac Comments on SEC Findings Against Jiaqiang "Chiang" Li and 1Globe Capital
May 17, 2020
Sinovac Announces First Animal Study Results of Vaccine Against COVID-19 Published in SCIENCE
May 5, 2020
Sinovac Reports Unaudited Fourth Quarter 2019 Financial Results and Files 2019 Annual Report on Form 20-F
April 29, 2020
Sinovac Announces Commencement of Phase I Human Clinical Trial for Vaccine Candidate Against COVID-19
April 16, 2020
Sinovac Announces Approval of Human Clinical Trial for a Vaccine Candidate Against COVID-19
April 13, 2020